Paul Matteis
Stock Analyst at Stifel
(0)
# 4055
Out of 5,243 analysts
132
Total ratings
31.48%
Success rate
-5.35%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Vertex Pharmaceutica... | Maintains: Hold | 490 494 | 420.38 | 17.51% | 18 | Dec 16, 2024 | |
uniQure | Maintains: Strong Buy | 12 32 | 13.73 | 133.07% | 1 | Dec 16, 2024 | |
Sage Therapeutics | Maintains: Hold | 10 6 | 7.36 | -18.48% | 5 | Dec 16, 2024 | |
Alector | Downgrades: Hold | 4 | 1.72 | 132.56% | 4 | Dec 16, 2024 | |
Alto Neuroscience | Maintains: Buy | 32 10 | 4.51 | 121.73% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 44 60 | 18.3 | 227.87% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 36 | 29.02 | 24.05% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 115 87 | 62.85 | 38.42% | 8 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 41 66 | 15.35 | 329.97% | 3 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 13.37 | 161.78% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 50 53 | 33.2 | 59.64% | 5 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 215 295 | 252.24 | 16.95% | 12 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 26 21 | 17.23 | 21.88% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 12.85 | 125.68% | 1 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 141 144 | 141.3 | 1.91% | 8 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 315 287 | 142.47 | 101.45% | 6 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 5.53 | 261.66% | 1 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 2.88 | 316.67% | 1 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 26 | 2.22 | 1071.17% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 24 | 2.74 | 775.91% | 2 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 295 | n/a | n/a | 4 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 54 | n/a | n/a | 2 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 36 5 | 0.54 | 825.93% | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 54 32 | 7.55 | 323.84% | 1 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 1.89 | 1169.84% | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | n/a | n/a | 1 | Sep 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 1.7 | 1488.24% | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 26 | 8.26 | 214.77% | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 23 23 | n/a | n/a | 2 | Dec 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 150 140 | n/a | n/a | 7 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 8.25 | 69.7% | 1 | Mar 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 60 | n/a | n/a | 6 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3000 2280 | n/a | n/a | 1 | Oct 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 25 31 | n/a | n/a | 2 | Sep 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 18 | n/a | n/a | 2 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 53 64 | 11.49 | 457.01% | 1 | Feb 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 22 | n/a | n/a | 2 | Oct 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 340 | 20.16 | 1586.51% | 1 | Dec 21, 2016 |